170 related articles for article (PubMed ID: 11429162)
21. Molecular mechanism(s) of actinomycin-D induced sensitization of pancreatic cancer cells to CD95 mediated apoptosis.
Glazyrin AL; Chinni S; Alhasan S; Adsay VN; Vaitkevicius VK; Sarkar FH
Int J Oncol; 2002 Jan; 20(1):201-5. PubMed ID: 11743665
[TBL] [Abstract][Full Text] [Related]
22. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses.
Tu Y; Gardner A; Lichtenstein A
Cancer Res; 2000 Dec; 60(23):6763-70. PubMed ID: 11118064
[TBL] [Abstract][Full Text] [Related]
23. Bcl-xL mediates a survival mechanism independent of the phosphoinositide 3-kinase/Akt pathway in prostate cancer cells.
Yang CC; Lin HP; Chen CS; Yang YT; Tseng PH; Rangnekar VM; Chen CS
J Biol Chem; 2003 Jul; 278(28):25872-8. PubMed ID: 12738789
[TBL] [Abstract][Full Text] [Related]
24. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC
J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031
[TBL] [Abstract][Full Text] [Related]
25. Antiapoptotic signaling in LNCaP prostate cancer cells: a survival signaling pathway independent of phosphatidylinositol 3'-kinase and Akt/protein kinase B.
Carson JP; Kulik G; Weber MJ
Cancer Res; 1999 Apr; 59(7):1449-53. PubMed ID: 10197612
[TBL] [Abstract][Full Text] [Related]
26. Apoptosis signaling by the novel compound 3-Cl-AHPC involves increased EGFR proteolysis and accompanying decreased phosphatidylinositol 3-kinase and AKT kinase activities.
Farhana L; Dawson MI; Huang Y; Zhang Y; Rishi AK; Reddy KB; Freeman RS; Fontana JA
Oncogene; 2004 Mar; 23(10):1874-84. PubMed ID: 14981538
[TBL] [Abstract][Full Text] [Related]
27. Depolarization and neurotrophins converge on the phosphatidylinositol 3-kinase-Akt pathway to synergistically regulate neuronal survival.
Vaillant AR; Mazzoni I; Tudan C; Boudreau M; Kaplan DR; Miller FD
J Cell Biol; 1999 Sep; 146(5):955-66. PubMed ID: 10477751
[TBL] [Abstract][Full Text] [Related]
28. TRAIL-DISC formation is androgen-dependent in the human prostatic carcinoma cell line LNCaP.
Rokhlin OW; Taghiyev AF; Guseva NV; Glover RA; Syrbu SI; Cohen MB
Cancer Biol Ther; 2002; 1(6):631-7. PubMed ID: 12642685
[TBL] [Abstract][Full Text] [Related]
29. NF-kappaB overrides the apoptotic program of TNF receptor 1 but not CD40 in carcinoma cells.
Davies CC; Bem D; Young LS; Eliopoulos AG
Cell Signal; 2005 Jun; 17(6):729-38. PubMed ID: 15722197
[TBL] [Abstract][Full Text] [Related]
30. Wortmannin elevates tumor necrosis factor-related apoptosis-inducing ligand sensitivity in LNCaP cells through down-regulation of IAP-2 protein.
Seol JW; Lee YJ; Kang HS; Kim IS; Kim NS; Kwak YG; Kim TH; Seol DW; Park SY
Exp Oncol; 2005 Jun; 27(2):120-4. PubMed ID: 15995629
[TBL] [Abstract][Full Text] [Related]
31. PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes.
Larribere L; Khaled M; Tartare-Deckert S; Busca R; Luciano F; Bille K; Valony G; Eychene A; Auberger P; Ortonne JP; Ballotti R; Bertolotto C
Cell Death Differ; 2004 Oct; 11(10):1084-91. PubMed ID: 15243584
[TBL] [Abstract][Full Text] [Related]
32. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells.
Madge LA; Pober JS
J Biol Chem; 2000 May; 275(20):15458-65. PubMed ID: 10748004
[TBL] [Abstract][Full Text] [Related]
33. Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway.
Sumitomo M; Milowsky MI; Shen R; Navarro D; Dai J; Asano T; Hayakawa M; Nanus DM
Cancer Res; 2001 Apr; 61(8):3294-8. PubMed ID: 11309283
[TBL] [Abstract][Full Text] [Related]
34. Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis.
Joy AM; Beaudry CE; Tran NL; Ponce FA; Holz DR; Demuth T; Berens ME
J Cell Sci; 2003 Nov; 116(Pt 21):4409-17. PubMed ID: 13130092
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of hypoxia/reoxygenation-induced oxidative stress in HGF-stimulated antiapoptotic signaling: role of PI3-K and Akt kinase upon rac1.
Ozaki M; Haga S; Zhang HQ; Irani K; Suzuki S
Cell Death Differ; 2003 May; 10(5):508-15. PubMed ID: 12728249
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
Hayakawa J; Ohmichi M; Kurachi H; Kanda Y; Hisamoto K; Nishio Y; Adachi K; Tasaka K; Kanzaki T; Murata Y
Cancer Res; 2000 Nov; 60(21):5988-94. PubMed ID: 11085518
[TBL] [Abstract][Full Text] [Related]
37. PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells.
Hu H; Jiang C; Li G; Lü J
Carcinogenesis; 2005 Aug; 26(8):1374-81. PubMed ID: 15845651
[TBL] [Abstract][Full Text] [Related]
38. Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis-inducing ligand (TRAIL).
Rychahou PG; Murillo CA; Evers BM
Surgery; 2005 Aug; 138(2):391-7. PubMed ID: 16153452
[TBL] [Abstract][Full Text] [Related]
39. Selective Akt inactivation and tumor necrosis actor-related apoptosis-inducing ligand sensitization of renal cancer cells by low concentrations of paclitaxel.
Asakuma J; Sumitomo M; Asano T; Asano T; Hayakawa M
Cancer Res; 2003 Mar; 63(6):1365-70. PubMed ID: 12649200
[TBL] [Abstract][Full Text] [Related]
40. PI3 kinase integrates Akt and MAP kinase signaling pathways in the regulation of prostate cancer.
Goc A; Al-Husein B; Kochuparambil ST; Liu J; Heston WW; Somanath PR
Int J Oncol; 2011 Jan; 38(1):267-77. PubMed ID: 21109949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
